267 related articles for article (PubMed ID: 19779132)
21. Grapefruit juice ingestion significantly reduces talinolol bioavailability.
Schwarz UI; Seemann D; Oertel R; Miehlke S; Kuhlisch E; Fromm MF; Kim RB; Bailey DG; Kirch W
Clin Pharmacol Ther; 2005 Apr; 77(4):291-301. PubMed ID: 15903127
[TBL] [Abstract][Full Text] [Related]
22. Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide.
Shirasaka Y; Suzuki K; Nakanishi T; Tamai I
Pharm Res; 2010 Oct; 27(10):2141-9. PubMed ID: 20686826
[TBL] [Abstract][Full Text] [Related]
23. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I
J Pharm Sci; 2013 Jan; 102(1):280-8. PubMed ID: 23132664
[TBL] [Abstract][Full Text] [Related]
24. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2.
Romiti N; Tramonti G; Donati A; Chieli E
Life Sci; 2004 Dec; 76(3):293-302. PubMed ID: 15531381
[TBL] [Abstract][Full Text] [Related]
25. Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens.
Boddu SP; Yamsani MR; Potharaju S; Veeraraghavan S; Rajak S; Kuma SV; Avery BA; Repka MA; Varanasi VS
Pharmazie; 2009 Aug; 64(8):525-31. PubMed ID: 19746842
[TBL] [Abstract][Full Text] [Related]
26. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.
Schwarz UI; Hanso H; Oertel R; Miehlke S; Kuhlisch E; Glaeser H; Hitzl M; Dresser GK; Kim RB; Kirch W
Clin Pharmacol Ther; 2007 May; 81(5):669-78. PubMed ID: 17392718
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
Takanaga H; Ohnishi A; Matsuo H; Sawada Y
Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
[TBL] [Abstract][Full Text] [Related]
28. Effect of grapefruit juice and ritonavir on pharmacokinetics of lopinavir in Wistar rats.
Ravi PR; Vats R; Thakur R; Srivani S; Aditya N
Phytother Res; 2012 Oct; 26(10):1490-5. PubMed ID: 22308076
[TBL] [Abstract][Full Text] [Related]
29. Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol.
Kato Y; Miyazaki T; Kano T; Sugiura T; Kubo Y; Tsuji A
J Pharm Sci; 2009 Jul; 98(7):2529-39. PubMed ID: 19067419
[TBL] [Abstract][Full Text] [Related]
30. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
Pathak SM; Udupa N
Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
[TBL] [Abstract][Full Text] [Related]
31. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
Cvetkovic M; Leake B; Fromm MF; Wilkinson GR; Kim RB
Drug Metab Dispos; 1999 Aug; 27(8):866-71. PubMed ID: 10421612
[TBL] [Abstract][Full Text] [Related]
32. Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans.
Gramatté T; Oertel R; Terhaag B; Kirch W
Clin Pharmacol Ther; 1996 May; 59(5):541-9. PubMed ID: 8646825
[TBL] [Abstract][Full Text] [Related]
33. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles.
Strauch K; Lutz U; Bittner N; Lutz WK
Food Chem Toxicol; 2009 Aug; 47(8):1928-35. PubMed ID: 19445995
[TBL] [Abstract][Full Text] [Related]
34. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
Dresser GK; Kim RB; Bailey DG
Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
[TBL] [Abstract][Full Text] [Related]
35. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
Westphal K; Weinbrenner A; Zschiesche M; Franke G; Knoke M; Oertel R; Fritz P; von Richter O; Warzok R; Hachenberg T; Kauffmann HM; Schrenk D; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
[TBL] [Abstract][Full Text] [Related]
36. Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat.
Garver E; Hugger ED; Shearn SP; Rao A; Dawson PA; Davis CB; Han C
Drug Metab Dispos; 2008 Dec; 36(12):2492-8. PubMed ID: 18755851
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells.
Tourniaire F; Hassan M; André M; Ghiringhelli O; Alquier C; Amiot MJ
Mol Nutr Food Res; 2005 Oct; 49(10):957-62. PubMed ID: 16189799
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein.
Kumar S; Kwei GY; Poon GK; Iliff SA; Wang Y; Chen Q; Franklin RB; Didolkar V; Wang RW; Yamazaki M; Chiu SH; Lin JH; Pearson PG; Baillie TA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1161-71. PubMed ID: 12604693
[TBL] [Abstract][Full Text] [Related]
39. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
[TBL] [Abstract][Full Text] [Related]
40. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]